171 related articles for article (PubMed ID: 19522774)
1. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
3. [Serum neopterin in Behçet's disease].
Samsonov MIu; Prokaeva TB; Madanat V; Alekberova ZS; Nasonov EL; Fuks D; Vakhter Kh
Klin Med (Mosk); 1995; 73(5):53-5. PubMed ID: 8815280
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
5. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
[TBL] [Abstract][Full Text] [Related]
6. [Interferon-gamma and neopterin in alopecia areata].
Lortkipanidze NT; Tevzadze MSh; Kamkamidze GK
Georgian Med News; 2005 Jun; (123):53-7. PubMed ID: 16052058
[TBL] [Abstract][Full Text] [Related]
7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
8. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
9. [Interferon-gamma and neopterin in blood serum of patients with chronic periodontitis].
Bakhtadze MG; Margvelashvili VV; Kamkamidze GK
Georgian Med News; 2006 Jan; (130):50-3. PubMed ID: 16510912
[TBL] [Abstract][Full Text] [Related]
10. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
12. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
13. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy.
Tozkoparan E; Deniz O; Cakir E; Yaman H; Ciftci F; Gumus S; Ozcan O; Akgul OE; Bilgic H; Erbil K; Ekiz K
Int J Tuberc Lung Dis; 2005 Sep; 9(9):1040-5. PubMed ID: 16158898
[TBL] [Abstract][Full Text] [Related]
15. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
16. Level of neopterin, a marker of immune cell activation in gingival crevicular fluid, saliva, and urine in patients with aggressive periodontitis.
Ozmeriç N; Baydar T; Bodur A; Engin AB; Uraz A; Eren K; Sahin G
J Periodontol; 2002 Jul; 73(7):720-5. PubMed ID: 12146530
[TBL] [Abstract][Full Text] [Related]
17. Urinary neopterin levels in uveitis: is it a new activity marker?
Durukan AH; Hurmeric V; Akgul EO; Kilic S; Bayraktar MZ
Ocul Immunol Inflamm; 2007; 15(4):303-8. PubMed ID: 17763127
[TBL] [Abstract][Full Text] [Related]
18. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of neopterin in patients with lichen planus.
Krasowska D; Chodorowska G; Bartosińska J; Warmińska J; Jermak A; Kur A; Kowal A; Bogaczewicz J
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):346-50. PubMed ID: 16146010
[TBL] [Abstract][Full Text] [Related]
20. The levels of serum neopterin in Behçet's disease--objective marker of disease activity.
Köse O; Arca E; Akgül O; Erbil K
J Dermatol Sci; 2006 May; 42(2):128-30. PubMed ID: 16600572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
